Click here to submit Post PR News
Posts tagged "Dr. Reddy’s Laboratories"

Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F

Hyderabad, India, June 16, 2018 Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2018 was filed  →
Views : 569

Dr. Reddy’s Laboratories announces the launch of Raloxifene HCl Tablets, USP in the U.S. Market

Hyderabad, India and Princeton, NJ, USA. 11 November 2016 – Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Raloxifene hydrochloride tablets in 60 mg, a therapeutic equivalent generic version of Evista® (raloxifene  →
Views : 945



Create Free Account

........................................................................
You can create a free account with us to gain access to just released news and press releases about leading companies from across the world. Your free account can provide you with the latest industry and corporate information to help you take quick business decisions. With your free account, you can be amongst the first ones to know of the latest happenings. So Signup now !!.